Sun Pharma gets USFDA nod for generic duodenal ulcer capsules

Drug firm Sun Pharmaceutical Industries today said it has received final approval from the US health regulator for its generic Lansoprazole delayed- release capsules used for treating duodenal ulcer.

Sun Pharma receives USFDA nod for anti-cancer injection

Sun Pharmaceutical Industries today said it has received US health regulator`s approval to market generic version of Doxil injection, used in treating ovarian cancer in the American market.

Sun Pharma gets USFDA nod for nasal spray

Sun Pharmaceutical Industries today said it has received approval from the US health regulator to sell its generic version of Astelin in the American market.

Dr Reddy`s, Sun Pharma get USFDA nod for heart disease drug

Drug firms Dr Reddy`s Laboratories, Sun Pharma and Aurobindo Pharma today said they have received US health regulator`s approval to sell generic Plavix, used in treating heart diseases, in the American market.

Sun gets support of Glass Lewis in its takeover battle Vs Taro

Sun Pharma on Tuesday said proxy advisory firm Glass Lewis & Co has recommended that shareholders of Israeli drug firm Taro should vote against the board`s proposals in the annual general meeting in month-end.

Sun Pharma gets USFDA`s tentative nod for Strattera capsules

Sun Pharmaceutical Industries on Thursday said it has got tentative approval from the US drug regulator for its generic product Strattera used in the treatment of mental disorders.

Sun Pharma settles dispute with MedImmune for cancer drug

Sun Pharmaceutical Industries on Monday
said it has settled its dispute with US-based pharma firm
MedImmune for marketing a generic version of latter`s Ethyol,
a drug used in the treatment of head and neck cancer.